Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BC-PIV SARS-CoV-2 vaccine - BioComo/MediciNova/Mie University

Next Previous
Drug Profile

BC-PIV SARS-CoV-2 vaccine - BioComo/MediciNova/Mie University

Alternative Names: BC-PIV based SARS-CoV-2 vaccine - BioComo/MediciNova/Mie University; BC-PIV SARS-COV-2 vaccine

Latest Information Update: 05 Mar 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator BioComo; Mie University
  • Developer BioComo; MediciNova; Mie University
  • Class COVID-19 vaccines; Peptide vaccines; Synthetic vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued COVID 2019 infections

Most Recent Events

  • 03 Mar 2021 Discontinued - Preclinical for COVID-2019 infections (Prevention) in Japan (IM)
  • 03 Mar 2021 Discontinued - Preclinical for COVID-2019 infections (Prevention) in Japan (Intranasal)
  • 23 Sep 2020 Interim immunogenicity data from preclinical in COVID-2019 infections released by MediciNova

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top